Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Identification of explanatory modifiers for the phenotypic heterogeneity of dominant RYR1 myopathies

FY 2019-20

Summary
"Neuromuscular diseases are known to be highly heterogeneous with a single variant often associated with a large variety of phenotypes. This heterogeneity complicates the diagnostic process leaving many patients without a prognosis or ideal clinical management and may even preclude the development of viable treatments. Mutations in RYR1 (Ryanodine receptor 1) have been previously associated with several diseases including central core disease, multiminicore disease, and malignant hypothermia susceptibility. However, this phenotypic variability remains unexplained, especially among patients with the same variant. We hypothesize that transcriptomic and epigenomic signatures could explain the differences in severity of RYR1 mutations. Our study comprises of 21 individuals from the region of Saguenay-Lac-Saint-Jean who carry the same heterozygous missense mutation (c.526G A), but present diverse phenotypes within and between families. In order to study this heterogeneity, we will first stratify patients according to phenotypic severity. Next, we will identify transcriptomic signatures that vary between subgroups and controls using mRNA and microRNA sequencing of muscle tissue. Finally, we will perform whole genome bisulfite sequencing to identify epigenetic signatures such as differential methylation that differ between subgroups and controls. This research will provide insight into the genes and biological pathways associated with heterogeneity of RYR1 mutations that may be applicable to other neuromuscular diseases. Furthermore, these signatures will improve the quality of life of affected patients by advancing diagnostic methods, evaluation of prognosis, and management of care and by driving the identification of new treatments. "
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428857
Name
Hauteclocque Jennifer D
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification of explanatory modifiers for the phenotypic heterogeneity of dominant RYR1 myopathies
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Epigenetics; Founder Population; Heterogeneity; Neuromuscular Disease; Next Generation Sequencing; Ryr1 Mutation
Abstract
"Neuromuscular diseases are known to be highly heterogeneous with a single variant often associated with a large variety of phenotypes. This heterogeneity complicates the diagnostic process leaving many patients without a prognosis or ideal clinical management and may even preclude the development of viable treatments. Mutations in RYR1 (Ryanodine receptor 1) have been previously associated with several diseases including central core disease, multiminicore disease, and malignant hypothermia susceptibility. However, this phenotypic variability remains unexplained, especially among patients with the same variant. We hypothesize that transcriptomic and epigenomic signatures could explain the differences in severity of RYR1 mutations. Our study comprises of 21 individuals from the region of Saguenay-Lac-Saint-Jean who carry the same heterozygous missense mutation (c.526G A), but present diverse phenotypes within and between families. In order to study this heterogeneity, we will first stratify patients according to phenotypic severity. Next, we will identify transcriptomic signatures that vary between subgroups and controls using mRNA and microRNA sequencing of muscle tissue. Finally, we will perform whole genome bisulfite sequencing to identify epigenetic signatures such as differential methylation that differ between subgroups and controls. This research will provide insight into the genes and biological pathways associated with heterogeneity of RYR1 mutations that may be applicable to other neuromuscular diseases. Furthermore, these signatures will improve the quality of life of affected patients by advancing diagnostic methods, evaluation of prognosis, and management of care and by driving the identification of new treatments. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hauteclocque, Jennifer D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~